Thirty-two albino male rat Ss were randomly assigned to four groups which were trained to perform a conditioned avoidance response to a criterion of acquisition. They were tested for retention at 24 hand 72 h. In acquisition, three of the four groups were given MgPe while a control group was given a placebo. After 24 h, two groups were drug-treated and two were placebo-treated. After 72 h, one group was drug-treated and three were placebotreated. It was found that MgPe did facilitate learning, but not retention. It was concluded that differences in retention were probably related to the acquisition process and not to MgPe.
The purpose of this experiment was to investigate the effects of magnesium pemoline (MgPe) on the learning and extinction of a conditioned avoidance response by rats. It was hypothesized that in acquisition Ss treated with MgPe would show a shorter latency of response, a higher proportion of avoidances and fewer trials to a criterion of learning. The hypothesis tested in extinction was that drug-treated Ss would require more trials to criterion than controls.
Subjects. The Ss were 32 naive male albino rats (240 to 420 g) obtained from the University of Arkansas Animal Science Center (local strain).
Apparatus. The apparatus used was a one-way avoidance box. The Ss' task was to jump a hurdle 3 in. hlgh to pass from the shock side to the safe side. The apparatus and the reasons for using it have been described elsewhere (McCarroll & Korbel, 1967) . The unconditioned stimulus (UCS) was a 0.3 rnA shock delivered through brass rods by a Grason-Stadler (E6070B) shock generator and scrambling mechanism. The conditioned stimulus (CS) was presented by a buzzer of low intensity which was situated below the floor of the shock compartment. The interstimulus interval was 5 sec. Latency and trials to criterion were used as the measures of Ss' acquisition behavior. In extinction, trials to criterion constituted the only measure since latency scores could not be obtained for all Ss due to the fact that some extinguished by the flfst trial. The MgPe was prepared in suspension form in 0.5% carboxymethycellulose which was filtered through a Seitz bacteriological filter before the MgPe was added. 2 Each S was injected intraperitoneally with 3.1 mg of MgPe which was approximately IO mg/kg body weight of each rat. All Ss were injected 30 min before they were to be tested. All Ss were run by the first author who did not know at the time whether a S was drug or placebo-treated. 3 Procedure. All Ss were tested at acquisition and at two extinction sessions, after 24 hand 72 h. The 32 Ss were assigned randomly to four groups. Group El received MgPe at acquisition and at both extinction sessions; E2 received MgPe at acquisition and the first extinction session, but the placebo (carboxymethylcellulose) at the second extinction session; E3 received MgPe at acquisition and the placebo at both extinction sessions; C received the placebo at all sessions.
The criterion for acquisition was nine out of 10 successful avoidance responses; i.e., crOSSing from the shock side to the safe side before UCS onset. After thls criterion was met, Ss were tested in extinction after 24 hand 72 h. The criterion of extinction consisted of failure to make successive avoidance responses. The procedure in extinction was the same as in acquisition with the exception of UCS presentation. The intertrial interval, approximately 1 min for all trials, was the time lapse between replacement of S in the shock compartment and the beginning of the next trial.
Results. Since the latency scores were heterogeneous in variance a logarithmic transformation was performed in order to make the analysis of variance design applicable (posttransforrnation Cochran C = 0.33, p > .05). The level of significance was set at 0.05 for all statistical tests. A significant difference was obtained between the drug groups and the control group for the first 10 acquisition trials with the drug groups having a shorter latency of response (F = 6.30, df = 1/30, p < .05) (see Fig. 1 ).
Psychon. Sci., 1968, Vol 11 (7) The mean latency scores of each S on acquisition for the drug groups and the placebo group were analyzed with the MannWhitney U test. It was found that drug-treated Ss had a shorter mean avoidance time than did control Ss over all acquisition trials (z = 2.69, p = .01). The mean latency scores of the last nine avoidance trials were also compared for all groups. No significant differences were found, indicating that Ss learned the task to the same level in terms of latency of response as well as the number of trials to criterion. The acquisition data were also analyzed for proportion of avoidances, i.e., ratio of number of avoidance responses to the total number of acquisition responses. Drugtreated groups had a significantly higher ratio of avoidance responses than the placebo group (z = 2.30, p = .01).
The trials to criterion data in acquistion and extinction were analyzed using the Mann-Whitney U test (see Table 1 ). In acquisition, Groups El, E2, and E3 did not differ from C as was predicted (z = 1.44, p = 0.07). In the first extinction session E I, E2, and E3 did differ significantly from C (z = 1.86, p = .03).
Also, the drug-treated groups (E I and E2) differed significantly from placebo-treated groups (E3 and C) with the drug-treated groups requiring more trials to criterion (z = 1.85, p = 0.03). In the second extinction session, Groups E 1, E2, and E3 required significantly more trials to criterion than did C (z = I. 70, p = .04).
However, the drug-treated group (El) did not differ from the placebo-treated groups (z = 1.22, p = 0.11 ).,,5
Discussion. From the results of the trials to criterion data in acquisition it must be concluded that there was no difference between the drug-treated and placebo-treated groups. However, other measures of acquisition did permit rejection of the hypothesis of no differences. The latency measures showed three important differences: (I) the drug-treated groups had significantly shorter latencies for the first 10 acquisition trials, whlch clearly supports the results of previous investigators (p\otnikoff, 1966; Beach & Kimble, 1967; Frey & Polidora, 1967) ; (2) the drug groups had a shorter mean avoidance time over all acquisition trials; and (3) the drug groups had a significantly higher proportion of avoidances. Beach & Kimble (1967) have called the proportion of avoidances the most meaningful measure of learning. These data for acquisition indicate that MgPe did facilitate the learning of a conditioned avoidance response in terms of the latency of response and the proportion of avoidances, although the trials to criterion measure did not show this difference
In the first extinction session, the data indicated that there was a significant difference between combined drug groups and the placebo group, which may have been related to the effects of the acquisition process. Also in the first extinction session Groups EI and E2 were significantly different from E3 and C. Thus the obtained differences between drug groups and placebo groups could be interpreted as due to either the effects of the drug or to the acquisition session. In the second extinction session the only drug-treated group was not different from the placebo-treated groups. However, as in the first extinction session Groups EI. E2, and E3 combined were Significantly different from C. Again, the retention observed appears related to the acquisition session rather than to the effects of the drug.
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In summary, it was concluded that the hypothesis of no difference in learning between groups could be rejected for the acquisition session. However, in evaluating the effects of MgPe on retention for both extinction sessions, it was concluded that there was no apparent relationship between drug-treated and placebo-treated groups. The only consistently significant differences in extinction were between the three groups that were treated with MgPe before acquisition and the placebo-treated group. Thus the observed differences in extinction appear related to the acquisition process and not to the effects of MgPe.
